Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 39
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Endocrinology ; 163(2)2022 02 01.
Artigo em Inglês | MEDLINE | ID: mdl-34967898

RESUMO

Leydig cells produce androgens that are essential for male sex differentiation and reproductive function. Leydig cell function is regulated by several hormones and signaling molecules, including growth hormone (GH). Although GH is known to upregulate Star gene expression in Leydig cells, its molecular mechanism of action remains unknown. The STAT5B transcription factor is a downstream effector of GH signaling in other systems. While STAT5B is present in both primary and Leydig cell lines, its function in these cells has yet to be ascertained. Here we report that treatment of MA-10 Leydig cells with GH or overexpression of STAT5B induces Star messenger RNA levels and increases steroid hormone output. The mouse Star promoter contains a consensus STAT5B element (TTCnnnGAA) at -756 bp to which STAT5B binds in vitro (electrophoretic mobility shift assay and supershift) and in vivo (chromatin immunoprecipitation) in a GH-induced manner. In functional promoter assays, STAT5B was found to activate a -980 bp mouse Star reporter. Mutating the -756 bp element prevented STAT5B binding but did not abrogate STAT5B-responsiveness. STAT5B was found to functionally cooperate with DNA-bound cJUN. The STAT5B/cJUN cooperation was only observed in Leydig cells and not in Sertoli or fibroblast cells, indicating that additional Leydig cell-enriched transcription factors are required. The STAT5B/cJUN cooperation was lost only when both STAT5B and cJUN elements were mutated. In addition to identifying the Star gene as a novel target for STAT5B in Leydig cells, our data provide important new insights into the mechanism of GH and STAT5B action in the regulation of Leydig cell function.


Assuntos
Hormônio do Crescimento/farmacologia , Células Intersticiais do Testículo/metabolismo , Fosfoproteínas/genética , Proteínas Proto-Oncogênicas c-jun/fisiologia , Fator de Transcrição STAT5/genética , Animais , Sequência de Bases , Sítios de Ligação , Linhagem Celular , DNA/química , DNA/metabolismo , Expressão Gênica/efeitos dos fármacos , Células Intersticiais do Testículo/classificação , Masculino , Camundongos , Fosfoproteínas/análise , Fosfoproteínas/fisiologia , Regiões Promotoras Genéticas , RNA Mensageiro/análise , Fator de Transcrição STAT5/análise , Fator de Transcrição STAT5/fisiologia , Regulação para Cima/efeitos dos fármacos
2.
Med Mol Morphol ; 54(3): 296-300, 2021 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-33452913

RESUMO

Secretory carcinoma of the salivary glands is a relatively new disease concept, and is characterized by "morphological resemblance to mammary secretory carcinoma and ETV6-NTRK3 gene fusion." Herein we describe a confusing case and briefly discuss practical diagnostic problems. The patient was a 71-year-old Japanese man who had a tumor consistent with secretory carcinoma at the microscopic and immunohistochemical levels. Immunohistochemically, EMA and S100 protein were noted to be positive along with various cytokeratins as well as mammaglobin and pSTAT5. Moreover, vimentin was focally positive. Smooth muscle actin, p63, p40, and androgen receptor were negative. However, a search using fluorescence in situ hybridization did not reveal a definite split signal for the ETV6 gene. It is presumed that confirming the diagnosis of secretory carcinoma without genetic retrieval will be accepted as a diagnostic method, and we hope that worldwide general recognition may earlier reach "gradual acceptance."


Assuntos
Biomarcadores Tumorais/análise , Carcinoma Secretor Análogo ao Mamário/diagnóstico , Neoplasias Parotídeas/diagnóstico , Proteínas Proto-Oncogênicas c-ets/análise , Proteínas Repressoras/análise , Idoso , Regulação Neoplásica da Expressão Gênica , Humanos , Imuno-Histoquímica , Queratinas/análise , Queratinas/genética , Masculino , Carcinoma Secretor Análogo ao Mamário/metabolismo , Carcinoma Secretor Análogo ao Mamário/patologia , Neoplasias Parotídeas/metabolismo , Neoplasias Parotídeas/patologia , Proteínas S100/análise , Proteínas S100/genética , Fator de Transcrição STAT5/análise , Fator de Transcrição STAT5/genética , Variante 6 da Proteína do Fator de Translocação ETS
3.
Brain Res ; 1751: 147189, 2021 01 15.
Artigo em Inglês | MEDLINE | ID: mdl-33152340

RESUMO

A growth hormone (GH) injection is able to induce the phosphorylated form of the signal transducer and activator of transcription 5 (pSTAT5) in a large number of cells throughout the mouse brain. The present study had the objective to map the distribution of GH-responsive cells in the brain of rats that received an intracerebroventricular injection of GH and compare it to the pattern found in mice. We observed that rats and mice exhibited a similar distribution of GH-induced pSTAT5 in the majority of areas of the telencephalon, hypothalamus and brainstem. However, rats exhibited a higher density of GH-responsive cells than mice in the horizontal limb of the diagonal band of Broca (HDB), supraoptic and suprachiasmatic nuclei, whereas mice displayed more GH-responsive cells than rats in the hippocampus, lateral hypothalamic area and dorsal motor nucleus of the vagus (DMX). Since both HDB and DMX contain acetylcholine-producing neurons, pSTAT5 was co-localized with choline acetyltransferase in GH-injected animals. We found that 50.0 ± 4.5% of cholinergic neurons in the rat HDB coexpressed GH-induced pSTAT5, whereas very few co-localizations were observed in the mouse HDB. In contrast, rats displayed fewer cholinergic neurons responsive to GH in the DMX at the level of the area postrema. In summary, pSTAT5 can be used as a marker of GH-responsive cells in the rat brain. Although rats and mice exhibit a relatively similar distribution of GH-responsive neurons, some species-specific differences exist, as exemplified for the responsiveness to GH in distinct populations of cholinergic neurons.


Assuntos
Mapeamento Encefálico/métodos , Receptores da Somatotropina/análise , Fator de Transcrição STAT5/análise , Acetilcolina , Animais , Encéfalo/metabolismo , Tronco Encefálico/metabolismo , Colina O-Acetiltransferase/metabolismo , Neurônios Colinérgicos/metabolismo , Hormônio do Crescimento/metabolismo , Hormônio do Crescimento/farmacologia , Hipocampo/metabolismo , Hipotálamo/metabolismo , Infusões Intraventriculares , Masculino , Bulbo/metabolismo , Camundongos , Camundongos Endogâmicos C57BL , Fosforilação , Ratos , Ratos Long-Evans , Receptores da Somatotropina/metabolismo , Fator de Transcrição STAT5/metabolismo
4.
Med Mol Morphol ; 54(1): 23-30, 2021 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-32488412

RESUMO

Secretory carcinoma (SC) of the salivary gland is a relatively newly described disease, separate from acinic cell carcinoma (ACC), which frequently displays ETV6-NTRK3 gene fusion. However, the differences between SC and ACC remain unclear. Here, histological reevaluation of 12 formerly diagnosed ACC cases was performed, which yielded a new diagnosis of SC in four cases due to a lack of obvious acinar-like cells. Immunohistochemically, phosphorylated signal transducer and activator of transcription 5 (p-STAT5) was expressed in SC but not in ACC, whereas discovered on GIST-1 (DOG1) was expressed in ACC but not in SC. Molecular analysis was possible in three SC cases, of which two showed the ETV6-NTRK3 fusion transcript on reverse-transcription polymerase chain reaction, as well as breaks in the ETV6 gene on fluorescence in situ hybridization. However, the remaining SC cases did not show this fusion transcript. Recently, several reports have suggested that SC might not be adequately diagnosed if the focus is placed solely on the ETV6-NTRK3 fusion gene due to genetic diversity. In this regard, immunohistochemistry of p-STAT5 and DOG1 is expected to be a useful alternative diagnostic tool to discriminate SC from ACC.


Assuntos
Biomarcadores Tumorais/análise , Carcinoma de Células Acinares/diagnóstico , Imuno-Histoquímica , Proteínas de Fusão Oncogênica/genética , Neoplasias Parotídeas/diagnóstico , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Anoctamina-1/análise , Anoctamina-1/metabolismo , Biomarcadores Tumorais/genética , Biomarcadores Tumorais/metabolismo , Carcinoma de Células Acinares/genética , Carcinoma de Células Acinares/patologia , Erros de Diagnóstico , Feminino , Heterogeneidade Genética , Humanos , Hibridização in Situ Fluorescente , Masculino , Pessoa de Meia-Idade , Proteínas de Neoplasias/análise , Proteínas de Neoplasias/metabolismo , Glândula Parótida/patologia , Neoplasias Parotídeas/genética , Neoplasias Parotídeas/patologia , Fator de Transcrição STAT5/análise , Fator de Transcrição STAT5/metabolismo , Adulto Jovem
5.
J Chin Med Assoc ; 82(3): 202-208, 2019 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-30913116

RESUMO

BACKGROUND: This study was conducted to investigate the treatment efficacies and immunological mechanisms of action of dioscin in mice with chicken collagen type II-induced arthritis (CIA). METHODS: The CIA mice was randomly divided into the model group (M), dioscin group (D), and tripterygium group (T); a normal control group (C) was also included. Each group was orally administered with related drugs or an equal volume of solvent (group C) starting on the 21st day of primary immunity, after which the levels of T helper 17 cells (Th17), regulatory T cells (Tregs), and their related factors were detected on the 35th day. RESULTS: Compared to group C, group M exhibited significantly increased levels of interleukin 17 (IL-17) and IL-6 and decreased IL-27 (p < 0.05). Group D exhibited significantly decreased levels of IL-17 and IL-6 compared with group M (p < 0.05). Group M showed a significantly increased ratio of Th17 cells (p < 0.05), while dioscin significantly reduced this ratio (p < 0.05). Groups M and C showed no significant difference in the ratio of Tregs (p > 0.05) but dioscin significantly increased this ratio (p < 0.05). Group M significantly increased signal transducer and activator of transcription 3 (STAT3) and STAT5 compared with that in group C (p < 0.05), while the T and D groups showed significantly reduced levels of STAT3 and STAT5 (p < 0.05). CONCLUSION: Dioscin may affect the differentiation of Th17 and Tregs and secretion of related factors by regulating CD4 T cell subset-related signal transduction and the expression of transcription-activating factor STAT3 and STAT5, thus exerting useful immunoregulatory roles in CIA mice.


Assuntos
Artrite Experimental/tratamento farmacológico , Diosgenina/análogos & derivados , Linfócitos T Reguladores/efeitos dos fármacos , Células Th17/efeitos dos fármacos , Animais , Artrite Experimental/imunologia , Galinhas , Colágeno Tipo II , Diosgenina/farmacologia , Interleucina-17/sangue , Interleucina-6/sangue , Interleucinas/fisiologia , Masculino , Camundongos , Camundongos Endogâmicos DBA , Fator de Transcrição STAT3/análise , Fator de Transcrição STAT5/análise , Linfócitos T Reguladores/imunologia , Células Th17/imunologia
6.
Oncology ; 91(2): 90-100, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27305144

RESUMO

OBJECTIVE: The purpose of this study was to reduce the time to tumor onset in a diethylnitrosamine (DEN)-induced hepatocellular carcinoma (HCC) swine model via partial liver embolization (PLE) and to characterize the model for use in translational research. METHODS: Eight Yucatan miniature pigs were injected intraperitoneally with either saline (n = 2) or DEN (n = 6) solution weekly for 12 weeks. Three of the DEN-treated pigs underwent PLE. The animals underwent periodic radiological evaluation, liver biopsy, and blood sampling, and full necropsy was performed at study termination (∼29 months). RESULTS: All DEN-treated pigs developed hepatic adenoma and HCC. PLE accelerated the time to adenoma development but not to HCC development. Biomarker analysis results showed that IGF1 levels decreased in all DEN-treated pigs as functional liver capacity decreased with progression of HCC. VEGF and IL-6 levels were positively correlated with disease progression. Immunohistochemical probing of HCC tissues demonstrated the expression of several important survival-promoting proteins. CONCLUSION: To our knowledge, we are the first to demonstrate an accelerated development of hepatic neoplasia in Yucatan miniature pigs. Our HCC swine model closely mimics the human condition (i.e., progressive disease stages and expression of relevant molecular markers) and is a viable translational model.


Assuntos
Adenoma/sangue , Adenoma/patologia , Carcinoma Hepatocelular/sangue , Modelos Animais de Doenças , Neoplasias Hepáticas Experimentais/sangue , Neoplasias Hepáticas Experimentais/patologia , Adenoma/induzido quimicamente , Animais , Carcinoma Hepatocelular/induzido quimicamente , Carcinoma Hepatocelular/patologia , Dietilnitrosamina , Embolia/induzido quimicamente , Feminino , Hormônio do Crescimento/sangue , Fator de Crescimento Insulin-Like I/metabolismo , Interleucina-6/sangue , Janus Quinase 2/análise , Neoplasias Hepáticas Experimentais/induzido quimicamente , Veia Porta , Receptores de Somatomedina/análise , Fator de Transcrição STAT3/análise , Fator de Transcrição STAT5/análise , Suínos , Porco Miniatura , Fatores de Tempo , Fator A de Crescimento do Endotélio Vascular/sangue , alfa-Fetoproteínas/metabolismo
7.
Oncotarget ; 6(41): 43255-66, 2015 Dec 22.
Artigo em Inglês | MEDLINE | ID: mdl-26657728

RESUMO

BACKGROUND: Regulatory T cells (Tregs) are key players in immune tolerance. They express the transcription factor FOXP3 and are dependent of the STAT5 signaling for their homeostasis. So far, the study of phosphorylated epitopes by flow cytometry required treating the cells with methanol, which is harmful for several epitopes. METHODS: Here we assessed whether the PerFix EXPOSE reagent kit (PFE)(Beckman Coulter) allowed monitoring the phosphorylation level of STAT5 in Treg subpopulations together with complex immunophenotyping. Results observed with the PFE kit were compared to those observed without cell permeabilization for surface markers, with paraformaldehyde permeabilization for non-phosphorylated intracellular epitopes, and with methanol-based permeabilization for phosphoSTAT5 staining. RESULTS: In human PBMCs, the PFE kit allowed the detection of surface antigens, FOXP3, KI67 and phosphoSTAT5 in similar proportions to what was observed without permeabilization (for surface antigens), or with PFA or methanol permeabilizations for FOXP3/KI67 and phosphoSTAT5, respectively. Comparable observations were made with murine splenocytes. Further, the PFE kit allowed determining the response of different human and murine Treg subsets to IL-2. It also allowed demonstrating that human Treg subsets with the highest levels of phosphoSTAT5 had also the highest suppressive activity in vitro, and that anti-thymocyte glogulin (ATG) induced Treg independently of the STAT5 pathway, both in vitro and in vivo. CONCLUSIONS: We have validated a multicolor staining method that allows monitoring phosphoSTAT5 levels in Treg subsets. This staining could be useful to monitor responses of various Treg subsets to IL-2 therapy.


Assuntos
Fator de Transcrição STAT5/análise , Coloração e Rotulagem/métodos , Subpopulações de Linfócitos T/imunologia , Linfócitos T Reguladores/imunologia , Adulto , Animais , Feminino , Citometria de Fluxo/métodos , Xenoenxertos , Humanos , Imunofenotipagem/métodos , Masculino , Camundongos , Camundongos Endogâmicos NOD , Camundongos SCID , Fosforilação , Adulto Jovem
8.
Pathology ; 47(7): 673-7, 2015 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-26517624

RESUMO

Few studies have comprehensively analysed histopathological findings of bone marrow clots for diagnosis of haematopoietic cell dysplasia. In particular, a limited number of studies have assessed the use of haematoxylin and eosin (H&E) staining, which is generally considered less informative than May-Giemsa staining. In the current study, the utility of bone marrow clot specimens for diagnosis was examined using H&E staining and immunohistochemistry. Patients with myelodysplastic syndromes (MDS) and myelodysplastic/myeloproliferative neoplasm (MDS/MPN), including chronic myelomonocytic leukaemia (CMML), atypical chronic myeloid leukaemia (aCML) lacking Philadelphia chromosome, and juvenile myelomonocytic leukaemia (JMML), were selected for histological evaluation. H&E stained specimens were advantageous for observation of atypical basophilic staining of the cytoplasm and nucleus related to dysplasia. This finding was significantly supported for both MDS and MDS/MPN (p < 0.05 versus May-Giemsa staining); therefore, we concluded that H&E staining could be used for identification of dysplastic cells. In addition, despite the loss of tissue structure, phosphorylated Stat5 immunostaining was sufficiently useful for the observation of myelodysplastic blasts. Thus, clot specimens are useful for diagnosis of haematopoietic dysplasia by pathologists.


Assuntos
Citodiagnóstico/métodos , Doenças Mieloproliferativas-Mielodisplásicas/diagnóstico , Fator de Transcrição STAT5/biossíntese , Coloração e Rotulagem/métodos , Biópsia por Agulha , Medula Óssea/patologia , Amarelo de Eosina-(YS) , Hematoxilina , Humanos , Imuno-Histoquímica , Fosforilação , Fator de Transcrição STAT5/análise
9.
J Dairy Sci ; 98(12): 8775-87, 2015 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-26387019

RESUMO

It has been previously shown that the long-term inhibition of milking-induced prolactin (PRL) release by quinagolide (QN), a dopamine agonist, reduces milk yield in dairy cows. To further demonstrate that PRL is galactopoietic in cows, we performed a short-term experiment that used PRL injections to restore the release of PRL at milking in QN-treated cows. Nine Holstein cows were assigned to treatments during three 5-d periods in a 3×3 Latin square design: 1) QN: twice-daily i.m. injections of 1mg of QN; 2) QN-PRL: twice-daily i.m. injections of 1mg of QN and twice-daily (at milking time) i.v. injections of PRL (2µg/kg body weight); and 3) control: twice-daily injections of the vehicles. Mammary epithelial cells (MEC) were purified from milk so that their viability could be assessed, and mammary biopsies were harvested for immunohistological analyses of cell proliferation using PCNA and STAT5 staining. In both milk-purified MEC and mammary tissue, the mRNA levels of milk proteins and BAX were determined using real-time reverse-transcription PCR. Daily QN injections reduced milking-induced PRL release. The area under the PRL curve was similar in the control and PRL injection treatments, but the shape was different. The QN treatment decreased milk, lactose, protein, and casein production. Injections of PRL did not restore milk yield but tended to increase milk protein yield. In mammary tissue, the percentage of STAT5-positive cells was reduced during QN but not during QN-PRL in comparison with the control treatment. The percentage of PCNA-positive cells was greater during QN-PRL injections than during the control or QN treatment and tended to be lower during QN than during the control treatment. In milk-purified MEC, κ-casein and α-lactalbumin mRNA levels were lower during QN than during the control treatment, but during QN-PRL, they were not different from the control treatment. In mammary tissue, the BAX mRNA level was lower during QN-PRL than during QN. The number of MEC exfoliated into milk was increased by QN injections but tended to be decreased by PRL injections. Injections of PRL also increased the viability of MEC harvested from milk. Although PRL injections at milking could not reverse the effect of QN treatment on milk production, their effects on cell survival and exfoliation and on gene expression suggest that the effect of QN treatment on the mammary gland is due to QN's inhibition of PRL secretion.


Assuntos
Aminoquinolinas/administração & dosagem , Bovinos/metabolismo , Lactação/efeitos dos fármacos , Glândulas Mamárias Animais/efeitos dos fármacos , Prolactina/administração & dosagem , Prolactina/antagonistas & inibidores , Animais , Caseínas/metabolismo , Proliferação de Células/efeitos dos fármacos , Suplementos Nutricionais , Agonistas de Dopamina/farmacologia , Células Epiteliais/química , Células Epiteliais/citologia , Feminino , Lactalbumina/metabolismo , Lactose/análise , Glândulas Mamárias Animais/química , Glândulas Mamárias Animais/citologia , Leite/citologia , Proteínas do Leite/genética , Antígeno Nuclear de Célula em Proliferação/análise , RNA Mensageiro/análise , Fator de Transcrição STAT5/análise
10.
Int J Nanomedicine ; 10: 3231-44, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25987838

RESUMO

Messenger RNA (mRNA), a single-strand ribonucleic acid with functional gene information is usually abnormally expressed in cancer cells and has become a promising biomarker for the study of tumor progress. Hairpin DNA-coated gold nanoparticle (hDAuNP) beacon containing a bare gold nanoparticle (AuNP) as fluorescence quencher and thiol-terminated fluorescently labeled stem-loop-stem oligonucleotide sequences attached by Au-S bond is currently a new nanoscale biodiagnostic platform capable of mRNA detection, in which the design of the loop region sequence is crucial for hybridizing with the target mRNA. Hence, in this study, to improve the sensitivity and selectivity of hDAuNP beacon simultaneously, the loop region of hairpin DNA was screened by bioinformatics strategy. Here, signal transducer and activator of transcription 5b (STAT5b) mRNA was selected and used as a practical example. The results from the combined characterizations using optical techniques, flow cytometry assay, and cell microscopic imaging showed that after optimization, the as-prepared hDAuNP beacon had higher selectivity and sensitivity for the detection of STAT5b mRNA in living cells, as compared with our previous beacon. Thus, the bioinformatics method may be a promising new strategy for assisting in the designing of the hDAuNP beacon, extending its application in the detection of mRNA expression and the resultant mRNA-based biological processes and disease pathogenesis.


Assuntos
Biologia Computacional/métodos , Ouro/química , Nanopartículas Metálicas/química , RNA Mensageiro , Fator de Transcrição STAT5 , Células Hep G2 , Humanos , RNA Mensageiro/análise , RNA Mensageiro/química , RNA Mensageiro/genética , Fator de Transcrição STAT5/análise , Fator de Transcrição STAT5/genética , Fator de Transcrição STAT5/metabolismo
11.
J Dairy Sci ; 98(5): 3133-42, 2015 May.
Artigo em Inglês | MEDLINE | ID: mdl-25771047

RESUMO

Prolactin (PRL) is important in the regulation of milk synthesis in mammary epithelial cells (MEC). In cattle, circulating levels of PRL are not limiting, suggesting the possible involvement of other factors that may control the response to PRL at the cellular level. The effects of milking frequency (MF) on milk synthesis are controlled locally within mammary glands and involve PRL signaling. To further investigate this relationship between MF and PRL signaling, udder halves of 17 dairy cows were milked either 4 times a day (4×) or once a day (1×) for 14 d in early lactation. Mammary biopsies were obtained 3 to 5h following milking from both udder halves of 10 cows, and changes in PRL and associated pathways were measured. The abundance of STAT5A mRNA was higher after 4× milking, whereas that of the PRL receptor (PRLR) and STAT3 were lower relative to that after 1× milking. In 4× mammary tissues, the protein levels of STAT5, activated STAT5, and ß1-integrin were higher, whereas the those of the long isoform of PRL receptor and activated STAT3 were lower than 1× tissues. The activation of STAT5 correlated strongly with major milk protein mRNA abundance (r=0.86 to 0.94) and ß1-integrin protein levels (r=0.91). These results confirm that major milk protein gene expression is associated with STAT5 activation and suggests that the STAT5 and ß1-integrin signaling pathways are linked. Modulation of ß1-integrin abundance in response to changes in MF may be a mechanism that controls the MEC ability to respond to PRL and therefore its secretory activity.


Assuntos
Indústria de Laticínios/métodos , Integrina beta1/metabolismo , Lactação/fisiologia , Glândulas Mamárias Animais/metabolismo , Fator de Transcrição STAT5/metabolismo , Animais , Bovinos , Células Epiteliais , Feminino , Expressão Gênica , Humanos , Integrina beta1/análise , Glândulas Mamárias Animais/química , Leite , Proteínas do Leite/genética , Prolactina/sangue , RNA Mensageiro/análise , RNA Mensageiro/metabolismo , Fator de Transcrição STAT5/análise , Fator de Transcrição STAT5/genética , Transdução de Sinais/fisiologia
12.
Mol Cell Biol ; 35(9): 1543-56, 2015 May.
Artigo em Inglês | MEDLINE | ID: mdl-25713103

RESUMO

Xbp1, a key mediator of the unfolded protein response (UPR), is activated by IRE1α-mediated splicing, which results in a frameshift to encode a protein with transcriptional activity. However, the direct function of Xbp1 in epithelial cells during mammary gland development is unknown. Here we report that the loss of Xbp1 in the mammary epithelium through targeted deletion leads to poor branching morphogenesis, impaired terminal end bud formation, and spontaneous stromal fibrosis during the adult virgin period. Additionally, epithelial Xbp1 deletion induces endoplasmic reticulum (ER) stress in the epithelium and dramatically inhibits epithelial proliferation and differentiation during lactation. The synthesis of milk and its major components, α/ß-casein and whey acidic protein (WAP), is significantly reduced due to decreased prolactin receptor (Prlr) and ErbB4 expression in Xbp1-deficient mammary epithelium. Reduction of Prlr and ErbB4 expression and their diminished availability at the cell surface lead to reduced phosphorylated Stat5, an essential regulator of cell proliferation and differentiation during lactation. As a result, lactating mammary glands in these mice produce less milk protein, leading to poor pup growth and postnatal death. These findings suggest that the loss of Xbp1 induces a terminal UPR which blocks proliferation and differentiation during mammary gland development.


Assuntos
Proliferação de Células , Proteínas de Ligação a DNA/metabolismo , Lactação , Glândulas Mamárias Animais/citologia , Glândulas Mamárias Animais/crescimento & desenvolvimento , Fatores de Transcrição/metabolismo , Animais , Diferenciação Celular , Células Cultivadas , Proteínas de Ligação a DNA/análise , Proteínas de Ligação a DNA/genética , Células Epiteliais/citologia , Células Epiteliais/metabolismo , Feminino , Deleção de Genes , Glândulas Mamárias Animais/ultraestrutura , Camundongos , Camundongos Endogâmicos C57BL , Prolactina/análise , Prolactina/metabolismo , Receptor ErbB-4/análise , Receptor ErbB-4/metabolismo , Fatores de Transcrição de Fator Regulador X , Fator de Transcrição STAT5/análise , Fator de Transcrição STAT5/metabolismo , Fatores de Transcrição/análise , Fatores de Transcrição/genética , Resposta a Proteínas não Dobradas , Proteína 1 de Ligação a X-Box
13.
Cell Res ; 24(12): 1387-402, 2014 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-25412660

RESUMO

T helper (TH)-cell subsets, such as TH1 and TH17, mediate inflammation in both peripheral tissues and central nervous system. Here we show that STAT5 is required for T helper-cell pathogenicity in autoimmune neuroinflammation but not in experimental colitis. Although STAT5 promotes regulatory T cell generation and immune suppression, loss of STAT5 in CD4+ T cells resulted in diminished development of experimental autoimmune encephalomyelitis (EAE), a mouse model of multiple sclerosis. Our results showed that loss of encephalitogenic activity of STAT5-deficient autoreactive CD4+ T cells was independent of IFN-γ or interleukin 17 (IL-17) production, but was due to the impaired expression of granulocyte-macrophage colony-stimulating factor (GM-CSF), a crucial mediator of T-cell pathogenicity. We further showed that IL-7-activated STAT5 promotes the generation of GM-CSF-producing CD4+ T cells, which were preferentially able to induce more severe EAE than TH17 or TH1 cells. Consistent with GM-CSF-producing cells being a distinct subset of TH cells, the differentiation program of these cells was distinct from that of TH17 or TH1 cells. We further found that IL-3 was secreted in a similar pattern as GM-CSF in this subset of TH cells. In conclusion, the IL-7-STAT5 axis promotes the generation of GM-CSF/IL-3-producing TH cells. These cells display a distinct transcriptional profile and may represent a novel subset of T helper cells which we designate as TH-GM.


Assuntos
Encefalomielite Autoimune Experimental/imunologia , Fator Estimulador de Colônias de Granulócitos e Macrófagos/imunologia , Fator de Transcrição STAT5/imunologia , Linfócitos T Auxiliares-Indutores/imunologia , Animais , Colite/genética , Colite/imunologia , Colite/patologia , Encefalomielite Autoimune Experimental/genética , Encefalomielite Autoimune Experimental/patologia , Deleção de Genes , Fator Estimulador de Colônias de Granulócitos e Macrófagos/análise , Interleucina-7/análise , Interleucina-7/imunologia , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Fator de Transcrição STAT5/análise , Fator de Transcrição STAT5/genética , Linfócitos T Auxiliares-Indutores/metabolismo , Linfócitos T Auxiliares-Indutores/patologia
14.
Pediatr Res ; 76(5): 453-8, 2014 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-25105258

RESUMO

BACKGROUND: Genetic variations associated with interstitial lung diseases (ILD) have not been extensively studied in Japanese infants. METHODS: Forty-three infants with unexplained lung dysfunction were studied. All 43, 22, and 17 infants underwent analyses of surfactant protein (SP)-C gene (SFTPC) and ATP-binding cassette A3 gene (ABCA3), SP-B gene (SFTPB), and SP-B western blotting, respectively. Two and four underwent assessment of granulocyte macrophage colony-stimulating factor-stimulating phosphorylation of signal transducer and activator of transcription-5 (pSTAT-5) and analyses of FOXF1 gene (FOXF1), respectively. RESULTS: ILD were diagnosed clinically in nine infants: four, three, and two had interstitial pneumonitis, hereditary pulmonary alveolar proteinosis (hPAP), and alveolar capillary dysplasia with misalignment of pulmonary veins (ACD/MPV), respectively. Genetic variations considered responsible were detected in six (67%) of the nine infants with ILD: three with hPAP (SFTPC p.Leu45Arg and p.Gln145fs, and ABCA3 p.Arg1583Trp/p.Val1495CysfsX21), two with interstitial pneumonitis (SFTPC p.Lys63Glu and p.Ser72Asn/p.Gly100Ala), and one with ACD/MPV (FOXF1 p.Leu300ArgfsX79). None showed SFTPB mutations or defects in pSTAT-5. The 17 bronchoalveolar lavage or tracheal aspirates contained enough SP-B protein. CONCLUSION: The SP-C abnormality was most prevalent, and SP-B deficiency was rare in Japanese infants with hereditary ILD.


Assuntos
Variação Genética , Doenças Pulmonares Intersticiais/genética , Transportadores de Cassetes de Ligação de ATP/genética , Idade de Início , Povo Asiático/genética , Feminino , Fatores de Transcrição Forkhead/genética , Marcadores Genéticos , Predisposição Genética para Doença , Hereditariedade , Humanos , Lactente , Recém-Nascido , Japão/epidemiologia , Leucócitos Mononucleares/química , Doenças Pulmonares Intersticiais/diagnóstico , Doenças Pulmonares Intersticiais/etnologia , Doenças Pulmonares Intersticiais/fisiopatologia , Doenças Pulmonares Intersticiais/terapia , Masculino , Fenótipo , Fosforilação , Proteinose Alveolar Pulmonar/congênito , Proteinose Alveolar Pulmonar/etnologia , Proteinose Alveolar Pulmonar/genética , Proteína B Associada a Surfactante Pulmonar/análise , Proteína B Associada a Surfactante Pulmonar/deficiência , Proteína B Associada a Surfactante Pulmonar/genética , Proteína C Associada a Surfactante Pulmonar/genética , Sistema de Registros , Fator de Transcrição STAT5/análise
15.
AIDS ; 28(6): 821-30, 2014 Mar 27.
Artigo em Inglês | MEDLINE | ID: mdl-24499954

RESUMO

OBJECTIVE: To examine the relationship of defects in interleukin (IL)-7-induced naive CD4 T-cell homeostasis with residual immune activation and CD4 T-cell senescence in HIV patients receiving antiretroviral therapy (ART) who exhibit persistent CD4 T-cell deficiency. DESIGN: IL-7 induced proliferation of, and IL-7 receptor signalling in, total and naive CD4 T cells of HIV patients who had low (<350 cells/µl) or normal (>500 cells/µl) CD4 T-cell counts on ART was examined and related to markers of CD4 T-cell activation and senescence and innate immune activation. METHODS: Total, naive (CD45RA CD27) and CD31 naive CD4 T cells from aviremic HIV patients (n=39) with nadir CD4 T-cell counts less than 100 cells/µl, who had received ART for a median time of 7 (range 1-11) years, were assessed for CD127 expression, proliferation (Ki67), signal transducer and activator of transcription 5 phosphorylation (pSTAT5) and CD127 modulation following IL-7 stimulation. Changes were related to proportions of CD4 T cells expressing HLA-DR or CD57 and plasma levels of sCD14, CXCL9 and CXCL10. RESULTS: Patients with CD4 T-cell deficiency exhibited lower expression of CD127 on total, naive and CD31 naive CD4 T cells. Downregulation of CD127 after culture with IL-7 correlated inversely with CD4 T-cell counts and directly with Ki67 expression. Induction of pSTAT5 in CD4 T-cell subsets was greater in patients with normal CD4 T-cell counts. CD127 expression correlated inversely with proportions of CD4CD57 T cells, and pSTAT5 induction correlated inversely with CD4 T-cell expression of HLA-DR and CD57. CONCLUSION: Defects of IL-7 signalling in HIV patients with persistent CD4 T-cell deficiency receiving ART are associated with CD4 T-cell activation and senescence.


Assuntos
Antirretrovirais/uso terapêutico , Linfócitos T CD4-Positivos/imunologia , Infecções por HIV/tratamento farmacológico , Infecções por HIV/imunologia , Interleucina-7/imunologia , Ativação Linfocitária , Transdução de Sinais , Adulto , Idoso , Antígenos CD/análise , Proliferação de Células , Feminino , Humanos , Imunofenotipagem , Antígeno Ki-67/análise , Masculino , Pessoa de Meia-Idade , Fator de Transcrição STAT5/análise
17.
Carcinogenesis ; 33(12): 2320-5, 2012 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-23161573

RESUMO

Nuclear localization of signal transducer and activator of transcription (Stat) 5 marks good prognosis in estrogen receptor/progesterone receptor-positive breast tumors. This positive characteristic is counteracted by studies in laboratory animals demonstrating that deregulated Stat5 activity may convert proper mammary development into a latent oncogenic process. Tumorigenesis is initiated during the parity cycles, most probably during pregnancy, when the activated Stat5 antagonizes or manipulates parity's protective mechanisms. For example, it can alter the differentiation/proliferation balance, induce growth hormone signaling, cause specific alteration in chromatin structure, inhibit tumor-suppressor activity and induce DNA damage that counteracts the enhanced DNA-damage response exerted by parity. Palpable tumors develop after a latent period from individual cells. This happens in the estropausal period in transgenic mice maintaining deregulated Stat5 activity in the mammary gland, or during involution, months after transplantation of transfected cells with constitutively active Stat5. Candidate vulnerable cells are those which maintain high nuclear Stat5 activity. Due to the hazardous outcome of deregulated Stat5 activity in these cells, such as induced DNA damage or high cyclin D1 activity, the gland is prone to transformation. The developing tumors are mostly adenocarcinomas or their subtypes. They are estrogen receptor-positive and maintain a specific Stat5 gene signature that allows tracking their inducer. From a clinical point of view, deregulated Stat5 activity represents a genuine risk factor for breast cancer. Monitoring Stat5 activity during vulnerable periods and developing specific tools for its suppression in breast epithelial cells could potentially limit new incidence of the disease.


Assuntos
Neoplasias da Mama/etiologia , Fator de Transcrição STAT5/fisiologia , Animais , Neoplasias da Mama/tratamento farmacológico , Neoplasias da Mama/patologia , Diferenciação Celular , Transformação Celular Neoplásica , Feminino , Humanos , Paridade , Gravidez , Prognóstico , Fator de Transcrição STAT5/análise , Fator de Transcrição STAT5/antagonistas & inibidores
18.
J Dairy Sci ; 95(7): 3711-21, 2012 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-22720928

RESUMO

The objective of this study was to characterize the circulating concentrations of insulin-like growth factor-I (IGF-I) and the hepatic expression of key genes regulating the somatotropic axis in cows divergent in genetic merit for fertility traits but with similar genetic merit for milk production traits. A total of 11 cows with good genetic merit for fertility (Fert+) and 12 cows with poor genetic merit for fertility (Fert-) underwent liver biopsy by percutaneous punch technique on d 20 (±6.7 d) prepartum and on d 2 (±1.5 d), d 58 (±3.7 d), d 145 (±13 d), and d 245 (±17.1 d) postpartum. Total RNA was isolated and the mRNA expression of growth hormone receptor (GHR 1A and GHRtot), IGF-I, janus tyrosine kinase 2 (JAK2), signal transducer and activator of transcription 5B (STAT5B), suppressor of cytokine signaling 3 (SOCS-3), acid-labile subunit (ALS), and IGF-binding proteins (IGFBP1 to IGFBP6) were measured by real-time quantitative PCR. During lactation, the circulating concentrations of IGF-I were 34% greater in Fert+ cows. The Fert+ cows had increased mean expression of IGF-I mRNA during the study; however, the difference in IGF-I mRNA abundance between Fert+ and Fert- cows was most pronounced at d 145 and 245. The expression of IGFBP3 and ALS transcript was similar in Fert+ and Fert- cows for the duration of the study. The Fert- cows, however, had greater expression of IGFBP2, IGFBP4, IGFBP5, and IGFBP6. Genotype had no effect on mRNA abundance of GHR 1A, STAT5B, JAK2, or SOCS-3. Genetic merit for fertility traits affects hepatic expression of key genes of the somatotropic axis regulating the synthesis, bioavailability, and stability of circulating IGF-I.


Assuntos
Bovinos/genética , Fertilidade/genética , Lactação/genética , Fígado/metabolismo , Prenhez/genética , Característica Quantitativa Herdável , Animais , Proteínas de Transporte/análise , Proteínas de Transporte/genética , Bovinos/fisiologia , Feminino , Fertilidade/fisiologia , Genes/genética , Genes/fisiologia , Glicoproteínas/análise , Glicoproteínas/genética , Proteínas de Ligação a Fator de Crescimento Semelhante a Insulina/análise , Proteínas de Ligação a Fator de Crescimento Semelhante a Insulina/genética , Fator de Crescimento Insulin-Like I/análise , Janus Quinase 2/análise , Janus Quinase 2/genética , Lactação/fisiologia , Fígado/química , Gravidez , Prenhez/fisiologia , Receptores da Somatotropina/análise , Receptores da Somatotropina/genética , Fator de Transcrição STAT5/análise , Fator de Transcrição STAT5/genética , Proteínas Supressoras da Sinalização de Citocina/análise , Proteínas Supressoras da Sinalização de Citocina/genética
19.
Reproduction ; 144(1): 83-90, 2012 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-22580369

RESUMO

Hyperphagia during pregnancy, despite rising concentrations of the satiety hormone leptin, suggests that a state of leptin resistance develops. This study investigated the satiety response and hypothalamic responses to leptin during pregnancy in the mouse. Pregnant (day 13) and nonpregnant mice received an i.p. injection of either leptin or vehicle and then 24-h food intake was measured. Further groups of pregnant and nonpregnant mice were perfused 2 h after leptin or vehicle injections and brains were processed for pSTAT3 and pSTAT5 immunohistochemistry. Leptin treatment significantly decreased food intake in nonpregnant mice. In pregnant mice, however, leptin treatment did not suppress food intake, indicating a state of leptin resistance. In the arcuate nucleus, leptin treatment increased the number of cells positive for pSTAT3, a marker of leptin activity, to a similar degree in both nonpregnant and pregnant mice. In the ventromedial nucleus (VMN), the leptin-induced increase in pSTAT3-positive cell number was significantly reduced in pregnant mice compared to that in nonpregnant mice. In nonpregnant mice, leptin treatment had no effect on the number of pSTAT5-positive cells, suggesting that in this animal model, leptin does not act through STAT5. In pregnant mice, basal levels of pSTAT5 were higher than in nonpregnant mice, and leptin treatment led to a decrease in the number of pSTAT5-positive cells in the hypothalamus. Overall, these results demonstrate that during pregnancy in the mouse, a state of leptin resistance develops, and this is associated with a reduced sensitivity of the VMN to leptin.


Assuntos
Ingestão de Alimentos/efeitos dos fármacos , Hipotálamo/efeitos dos fármacos , Leptina/farmacologia , Prenhez/fisiologia , Fator de Transcrição STAT5/metabolismo , Transdução de Sinais/efeitos dos fármacos , Animais , Núcleo Arqueado do Hipotálamo/química , Núcleo Arqueado do Hipotálamo/efeitos dos fármacos , Resistência a Medicamentos , Feminino , Hipotálamo/química , Hipotálamo/fisiologia , Camundongos , Camundongos Endogâmicos C57BL , Fosforilação/efeitos dos fármacos , Gravidez , Fator de Transcrição STAT3/análise , Fator de Transcrição STAT3/efeitos dos fármacos , Fator de Transcrição STAT3/metabolismo , Fator de Transcrição STAT5/análise , Fator de Transcrição STAT5/efeitos dos fármacos , Saciação/efeitos dos fármacos , Núcleo Hipotalâmico Ventromedial/química , Núcleo Hipotalâmico Ventromedial/efeitos dos fármacos
20.
Inflamm Res ; 61(5): 511-20, 2012 May.
Artigo em Inglês | MEDLINE | ID: mdl-22322482

RESUMO

OBJECTIVE: To explore the effects of 1,25-(OH)(2)D(3) and lipopolysaccharide (LPS) plus human recombinant interleukin-15 (IL-15) on expression of vitamin D receptor (VDR) and STAT5, and cytoskeletal rearrangement in human monocytes incubated with sera from type 2 diabetes (T2DM) patients and diabetic nephropathy (DN) patients with uremia. MATERIALS AND METHODS: Peripheral sera were isolated from healthy volunteers (control group, T2DM patients and DN uremic non-dialysis patients). After incubation with or without 1,25(OH)(2)D(3), THP-1 monocytes were treated with LPS plus IL-15 prior to the collection of cells and supernatants. VDR mRNA transcription was examined by RT-PCR, whilst THP-1 monocytic VDR, STAT5 and p-STAT5 expressions were investigated by Western blotting. Concentrations of IL-6 and monocyte chemoattractant protein-1 (MCP-1) in supernatants were assessed by ELISA. Immunofluorescence and a laser confocal microscopy was used to examine the expression of VDR and cytoskeletal proteins. RESULTS: Compared to the normal control, LPS and IL-15 down-regulate monocytic VDR expression in T2DM patients and DN uremic patients, whilst with cytoskeletal rearrangement, they up-regulate p-STAT5 expression as well as IL-6 and MCP-1 activity. Such effects could be in part blocked by 1,25-(OH)(2)D(3). CONCLUSION: The above results suggest that the anti-inflammatory mechanism of 1,25-(OH)(2)D(3) may be related to cytoskeletal proteins, VDR and STAT5 signaling pathway.


Assuntos
Anti-Inflamatórios/farmacologia , Calcitriol/farmacologia , Citoesqueleto/efeitos dos fármacos , Diabetes Mellitus Tipo 2/sangue , Nefropatias Diabéticas/sangue , Monócitos/efeitos dos fármacos , Receptores de Calcitriol/análise , Fator de Transcrição STAT5/análise , Proteínas Supressoras de Tumor/análise , Uremia/sangue , Adulto , Células Cultivadas , Quimiocina CCL2/biossíntese , Citoesqueleto/química , Feminino , Humanos , Interleucina-15/farmacologia , Interleucina-6/biossíntese , Lipopolissacarídeos/farmacologia , Masculino , Microscopia de Fluorescência , Pessoa de Meia-Idade , Monócitos/metabolismo , Receptores de Calcitriol/genética , Transdução de Sinais
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...